J. Atherall

Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor.

K. Scearce-Levie, A. Beresford, A. Medhurst, 2013, ACS medicinal chemistry letters.

Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.

G. Bernardinelli, Y. Filinchuk, C. Giachetti, 2008, Journal of medicinal chemistry.

Design, synthesis and biological evaluation of α-substituted isonipecotic acid benzothiazole analogues as potent bacterial type II topoisomerase inhibitors.

Edward M. Tyndall, J. Palmer, D. Davies, 2013, Bioorganic & medicinal chemistry letters.

SOME SULFONYL DERIVATIVES OF SALICYLIC ACID AND RELATED COMPOUNDS

R. Cremlyn, F. J. Swinbourne, J. Atherall, 1980 .